“BETTER OUTCOME OF HIGH-DOSE CEFTAZIDIME IN HEMATO – ONCOLOGICAL PATIENTS WITH INFECTIONS CAUSED BY EXTENSIVELY DRUG-RESISTANT PSEUDOMONAS AERUGINOSA”, Mediterr J Hematol Infect Dis, vol. 15, no. 1, p. e2023001, Dec. 2022, doi: 10.4084/MJHID.2023.001.